▲ Peaking
Business
MeiraGTx scores $400M from Oberland Capital to help get 2 gene therapies to commercialization
MeiraGTx has secured significant funding from Oberland Capital to accelerate the commercialization of two gene therapies.
1 news trends Newsylist has tracked involving Bota-Vec Acquisition Oberland Capital Cash Infusion And Catalysts — newest first.
MeiraGTx has secured significant funding from Oberland Capital to accelerate the commercialization of two gene therapies.